Citadel Advisors’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Citadel Advisors’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-745,132	Closed	-$7.36M	–	15897
2022 Q3	$7.36M	Buy	745,132 +2,243	+0.3%	+$22.1K	﹤0.01%	3231
2022 Q2	$7.27M	Sell	742,889 -502,455	-40%	-$4.93M	﹤0.01%	3137
2022 Q1	$12.2M	Sell	1,245,344 -303	-0%	-$2.96K	﹤0.01%	2657
2021 Q4	$12.2M	Sell	1,245,647 -166	-0%	-$1.62K	﹤0.01%	2724
2021 Q3	$12.1M	Buy	1,245,813 +528,687	+74%	+$5.12M	﹤0.01%	2742
2021 Q2	$6.94M	Buy	717,126 +6,237	+0.9%	+$60.6K	﹤0.01%	3751
2021 Q1	$6.83M	Buy	+710,889	New	+$6.88M	﹤0.01%	3635

Citadel Advisors's SHAC Position: Q4 2022 in Review

Citadel Advisors sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 745,132 shares — an estimated $7.36M sold.

Citadel Advisors first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $12.2M in Q4 2021. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Citadel Advisors reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Citadel Advisors sold 745,132 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $7.36M.
Citadel Advisors first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Citadel Advisors's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $12.2M in Q4 2021.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.